Total anomalous pulmonary venous connection surgery

Total anomalous pulmonary venous connection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Total anomalous pulmonary venous connection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
MRI
CT
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Case Studies
Case #1
Total anomalous pulmonary venous connection surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Total anomalous pulmonary venous connection surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Total anomalous pulmonary venous connection surgery
CDC on Total anomalous pulmonary venous connection surgery
Total anomalous pulmonary venous connection surgery in the news
Blogs on Total anomalous pulmonary venous connection surgery
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Total anomalous pulmonary venous connection surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Keri Shafer, M.D. [3]

Surgical Therapy

In TAPVC without obstruction, surgical redirection can be performed within the first month of life. With obstruction, surgery should be undertaken emergently. PGE1 should not be given because a patent ductus arteriosus adds even more volume into the already overloaded pulmonary flow.